show more articles
The chances of a cure for cancer in children have risen from 40% to 80% between 1973 and 2012.
francs are invested by the members of Interpharma each year in research & development in Switzerland. As a result, for every franc earned from sales in Switzerland, almost two are reinvested.
People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.
Our mission is to ensure that patients in Switzerland receive access to innovative medicines and therapies as quickly as possible.
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2020
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives